E-DRUG:Medicine Quality & Public Health Conference Registration Ends 31st August 2018
-------------------------------------------------------------------------------------------------
Dear Colleagues,
A reminder to the medicine quality and access community that conference registration will close soon, on the 31st August.
This is being organised by the Centre for Tropical Medicine & Global Health, University of Oxford.
Please see the conference website, with an updated program, at http://www.tropicalmedicine.ox.ac.uk/medicinequality2018/
where you will find more information.
The Conference has 26 partners and is supported by WHO and a great diversity of organisations spanning the diversity of subjects that need to be considered to ensure that we all have access to medicines that work and we can trust.
The Conference will be opened and then discussion led by a diversity of distinguished regulatory and public health experts. Please see:
https://www.tropicalmedicine.ox.ac.uk/medicinequality2018/speakers-2/
There is increasing interest in the neglected subject of poor quality medicines and other medical products, their epidemiology, origins, detection and impact and how to intervene to reduce their frequency. However, there has never been, that we are aware of, a dedicated large academic and programmatic international conference on the subject. The aims are to:
1. To bring together people from a diversity of backgrounds interested in the subject [public health, national regulatory authority, pharmacy, biomedical, chemist, law, ethics, cultural sciences, social sciences, public health education & engagement, international organisations, NGOs, development partners/donors in health, national procurement centres, the internet-sector] to learn and discuss together. As the field is a young one and fragmented we expect that all will benefit from this networking and discussion and greater consensus reached.
2. To discuss a wide range of relevant topics - including definitions, law, international guidelines, epidemiology, public health impact, ethics, patient and health worker knowledge, sociology of medicines engagement, physical and chemical analysis, packaging, regulation and potential interventions.
The conference will start with two days of scientific and operational research orientated talks and discussion, followed by three days of more policy-orientated discussion.
We look forward to welcoming you to the Conference and Oxford.
very best wishes,
Paul Newton & Caroline Caillet
IDDO/WWARN/LOMWRU, Medicine Quality Group, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR
Paul Newton <Paul.Newton@tropmedres.ac>